Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
Login to comment.